NexgenRx Inc. (TSXV:NXG)

NexgenRx Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 24, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	24	20	16	19	28	17
Market Cap Growth	16.99%	26.04%	-16.75%	-33.75%	67.66%	23.08%
Enterprise Value	24	20	16	19	30	19
Last Close Price	0.34	0.27	0.20	0.24	0.35	0.21
PE Ratio	64.84	46.95	-	-	7.00	7.93
PS Ratio	1.44	1.19	1.12	1.46	2.38	1.59
PB Ratio	2.98	2.57	2.01	2.11	2.90	3.04
P/TBV Ratio	7.72	8.13	9.26	10.01	16.49	-
P/FCF Ratio	12.54	18.37	12.93	27.52	7.61	6.63
P/OCF Ratio	11.92	17.00	12.15	17.48	7.36	6.33
EV/Sales Ratio	1.45	1.20	1.13	1.48	2.51	1.83
EV/EBITDA Ratio	15.89	14.11	229.95	12.31	8.95	8.00
EV/EBIT Ratio	19.28	16.56	-	65.55	13.49	11.43
EV/FCF Ratio	12.68	18.63	13.02	27.84	8.02	7.62
Debt / Equity Ratio	0.06	0.07	0.06	0.05	0.04	0.26
Debt / EBITDA Ratio	0.33	0.36	3.62	0.26	0.11	0.55
Debt / FCF Ratio	0.26	0.50	0.39	0.64	0.11	0.57
Asset Turnover	0.54	0.54	0.50	0.46	0.43	0.46
Quick Ratio	0.12	0.11	0.12	0.13	0.14	0.06
Current Ratio	1.12	1.10	1.06	1.09	1.07	0.97
Return on Equity (ROE)	8.30%	8.01%	-4.01%	-0.24%	52.75%	57.48%
Return on Assets (ROA)	2.56%	2.47%	-0.32%	0.65%	5.03%	4.55%
Return on Capital (ROIC)	9.13%	9.16%	-1.03%	1.85%	16.09%	16.36%
Return on Capital Employed (ROCE)	14.80%	14.90%	-	3.10%	22.20%	27.00%
Earnings Yield	2.00%	3.14%	-2.14%	-0.12%	14.28%	12.61%
FCF Yield	7.97%	5.44%	7.74%	3.63%	13.14%	15.09%
Dividend Yield	2.94%	3.70%	4.91%	4.14%	-	-
Payout Ratio	133.40%	147.78%	-	-	3.25%	-
Buyback Yield / Dilution	-9.69%	-8.51%	-0.28%	6.01%	-0.88%	-6.10%
Total Shareholder Return	-6.92%	-4.81%	4.63%	10.15%	-0.88%	-6.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.